Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Press Release

View printer-friendly version
2004 Cambridge-Boston Recipients of Amgen Award for Science Teaching Excellence Announced

CAMBRIDGE, Mass--April 28, 2004--Amgen Inc. (Nasdaq:AMGN), the world's largest biotechnology company, has announced the two science teachers in Cambridge-Boston, Mass., who are this year's recipients of the Amgen Award for Science Teaching Excellence. The Amgen awards honor public or private school science teachers, grades K-12, who demonstrate outstanding science teaching and have a great impact on the lives of their students. Each teacher will receive an unrestricted $10,000 award at a dinner event in May. For more information on the award please contact Amgen at the number below. The 2004 winners are:

  • Barbara Dorritie of Cambridge Rindge and Latin School, Cambridge, Mass.

  • Diana Christian of Economics and Business Academy, Boston, Mass.

Nominations are solicited every January and a panel of independent judges selects the winners. Judges base their decisions on evidence of the recipients' creativity and effectiveness in the classroom; their application and development of best practices in science education; their motivational ability; and their mastery of the subject matter and instructional skill.

In addition to the Cambridge-Boston program, the Amgen Award for Science Teaching Excellence is granted in Rhode Island; California; Colorado; Jefferson County, Kentucky; Puerto Rico; and Washington, locations where Amgen has facilities. Amgen has conducted the awards program for teaching excellence for 13 years in the U.S.

Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.

EDITOR'S NOTE: An electronic version of this news release may be accessed via our Web site at www.amgen.com. Journalists and media representatives may sign up to receive all news releases electronically at time of announcement by filling out a short form in the Media section of the Web site.

CONTACT: Amgen, Cambridge
Larry Bernard, 401-392-1683